TFC Financial Management’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$562 Hold
1
﹤0.01% 689
2025
Q4
$677 Hold
1
﹤0.01% 655
2025
Q3
$639 Hold
1
﹤0.01% 680
2025
Q2
$537 Sell
1
-2
-67% -$956 ﹤0.01% 662
2025
Q1
$1.26K Sell
3
-19
-86% -$8.25K ﹤0.01% 533
2024
Q4
$9.1K Sell
22
-1
-4% -$439 ﹤0.01% 362
2024
Q3
$11.6K Hold
23
﹤0.01% 358
2024
Q2
$11.2K Hold
23
﹤0.01% 334
2024
Q1
$12.4K Buy
23
+1
+5% +$546 ﹤0.01% 322
2023
Q4
$12.2K Buy
22
+1
+5% +$469 ﹤0.01% 319
2023
Q3
$9.18K Hold
21
﹤0.01% 350
2023
Q2
$10.5K Buy
21
+1
+5% +$479 ﹤0.01% 330
2023
Q1
$10K Hold
20
﹤0.01% 373
2022
Q4
$8.16K Hold
20
﹤0.01% 310
2022
Q3
$7K Hold
20
﹤0.01% 340
2022
Q2
$7K Hold
20
﹤0.01% 328
2022
Q1
$11K Hold
20
﹤0.01% 310
2021
Q4
$13K Hold
20
﹤0.01% 315
2021
Q3
$12K Hold
20
﹤0.01% 318
2021
Q2
$13K Hold
20
﹤0.01% 300
2021
Q1
$10K Hold
20
﹤0.01% 308
2020
Q4
$10K Hold
20
﹤0.01% 312
2020
Q3
$8K Buy
+20
New +$7.39K ﹤0.01% 312

Other funds holding IDXX

TFC Financial Management's IDXX Position: Q1 2026 in Review

TFC Financial Management held its Idexx Laboratories (IDXX) position steady in Q1 2026 at 1 share worth $562. The position accounts for ﹤0.01% of the portfolio, ranked #689.

TFC Financial Management first reported a position in IDXX in Q3 2020 and has held it in 23 quarters since. The position peaked at $13K in Q4 2021. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • TFC Financial Management held 1 share of Idexx Laboratories worth $562 as of Q1 2026.
  • TFC Financial Management left its Idexx Laboratories share count unchanged in Q1 2026.
  • Idexx Laboratories made up ﹤0.01% of TFC Financial Management's portfolio in Q1 2026, its #689 holding.
  • TFC Financial Management first reported a position in Idexx Laboratories in Q3 2020 and has held it in 23 quarters since.
  • TFC Financial Management's Idexx Laboratories position peaked at $13K in Q4 2021.
  • 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on TFC Financial Management's 13F filing for Q1 2026, filed 23 Apr 2026.